Advancing Scientific Breakthroughs for Healthy Vision
Around the world, eye disease afflicts millions of people whose lives and potential are diminished by partial or total loss of sight. For over 60 years, the Doheny Eye Institute has been at the forefront of eradicating eye disease, dedicated to providing state-of-the-art clinical services, and supporting leading researchers in the quest to find cures and treatments to stabilize and improve the precious sense of sight.
Today, with more than 45 million blind individuals in the world, and another 135 million people who are visually disabled, work to find cures and treatments is as urgent as ever. Retinitis pigmentosa, cataracts, glaucoma, macular degeneration and other treatable diseases are among the most persistent global health problems, although both diagnosis and treatment are attainable and affordable, given adequate funding for resources. Also, as the baby boomer generation ages, there is a growing need for diagnosis, treatment and research of eye disease that afflicts primarily elderly populations.
The work of the Doheny Eye Institute immediately impacts and improves the lives of those we treat locally, and through our networks we reach thousands more with innovative research, diagnosis and treatment that restores sight and changes lives.
Because of our cutting edge research and clinical expertise, the Doheny Eye Institute has been ranked among the top 10 ophthalmology programs in the nation by US News & World Report for the past 17 years. Doheny has served patients in Pasadena, Arcadia, Fountain Valley, Rancho Mirage, Riverside, Beverly Hills and Los Angeles. Between July 2012 and June 2013, clinics saw a unique total of 14,881 patients (a total of 46,670 clinical visits). In the period between July 2011 and June 2012, those numbers were 14,698 and 47,058, respectively.
As Doheny embarks on its new strategic partnership with UCLA and Stein Eye Institute, new clinics will open in Arcadia (now open), Pasadena (July or August 2014) and Fountain Valley (April or May 2014). The expanded scope of services is central to our core mission of diagnosis and treatment.
In addition to our clinical impact in the local region, Doheny's work enjoys dramatic international reach as hundreds of the most highly trained specialists of eye diseases have trained or practiced at Doheny Eye Institute. Training the leaders of the next generation of ophthalmologists and vision scientists is a major goal of the Institute. To date, 41 chairs of ophthalmology programs in the U.S. and around the world have trained at Doheny or served on the faculty. Hundreds more doctors and technicians have trained at Doheny. Presently, our alums deliver care and conduct research around the world in countries like Brazil and China, where eye disease continues to grow and linger as a major public health issue.
Decades of of success in pioneering research and creating healthy change have established Doheny Eye Institute as one of the world's premier institutions on the front lines of both fighting eye disease and preventing of loss of vision. Our Doheny Image Reading Center is uniquely equipped to enhance the value and utility of ophthalmic image interpretation in both clinical and research applications. This center provides tools to precisely characterize and quantify diseases of the eye with the latest imaging technology for addressing retinal disease. This year, in entering an historic alliance with UCLA and its world-class Stein Eye Institute, we are poised to realize more positive results than ever before. Our complementary research and clinical services mean that thousands more can benefit from the synergy and joint resources of these two world-class institutions.
The Doheny Eye Institute enjoys an international reputation among leading ophthalmologists as a premier institution. Doheny is able to capitalize on its reputation by recruiting the best in the field and training tomorrow's leaders in ophthalmology.
A key resource available to Doheny scientists is the group of specialized core laboratories, which provide equipment and expertise that researchers could not afford individually. These shared facilities include a tissue culture laboratory where tissues are sorted, prepared and preserved for study; a histopathology and immunology service providing tissue processing, staining and embedding of tissues into slides for research and teaching purposes; multi-million dollar microscopes for imaging tissues and cells; and a biostatistics module which aids scientists in the design of studies and analysis of data. Experienced technicians assist and train researchers in the use of laboratory equipment and processes.
Continuing our vital programs
As the Doheny Eye Institute is committed to extending diagnositc and clinical services, our board of directors has negotiated an historic strategic alliance with UCLA and Stein Eye Institute, another renowned institution for ophthalmic care with services that complement our own.
This partnership will secure the future of state-of-the-art ophthalmic care, treatment and research. The timing is critical, as the need for our services and research continues to grow. One example: age-related macular degeneration (AMD) affects more than 2 million Americans over the age of 50. By 2020, an additional 2.95 million are expected to be diagnosed with the disease. Doheny Eye Institute is one of the world's leading centers for new treatments for AMD. Doheny researchers have contributed to major studies of wet AMD therapies. They continue to perfect minimally invasive surgical procedures for wet AMD treatment, while leading the country's most advanced center for imaging in support of AMD clinical trials.
Mission and history
The Doheny Eye Institute was founded with authentic passion for finding cures to all disease that limits human sight. Mrs. Carrie Estelle Doheny, wife of the prominent Los Angeles oilman Edward L. Doheny, lost the sight in her left eye at the age of 69. Suddenly aware of the precious and delicate nature of the gift of sight, Mrs. Doheny created and funded the organization named for her in 1947.
Doheny Eye Institute expects to serve thousands of patients in clinics around Los Angeles and Orange Counties. We have emerged as a world leader in basic and clinical vision research and advanced patient care. The Institute's innovative research programs continually result in new diagnostic and treatment procedures and are respected internationally for research of the highest caliber.